HC Wainwright Reaffirms Buy Rating for PDS Biotechnology (NASDAQ:PDSB)
PDS Biotechnology (NASDAQ:PDSB – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $13.00 price target on the stock. Separately, Wall Street Zen raised PDS Biotechnology from a “sell” rating to a “hold” […]
